Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Myovant Sciences Ltd. Common Shares (NY: MYOV )

N/A UNCHANGED
Last Price Updated: 7:00 PM EST, Mar 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Myovant Sciences Ltd. Common Shares

Myovant Sciences Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022
From Myovant Sciences, Inc.
Via GlobeNewswire
MYOVANT SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV
From Kahn Swick & Foti, LLC
Via Business Wire
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
From Myovant Sciences, Inc.
Via GlobeNewswire
Myovant Sciences Appoints Ann Tomlin as Senior Vice President of Human Resources
From Myovant Sciences, Inc.
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Myovant Sciences Ltd. (NYSE - MYOV), ForgeRock, Inc. (NYSE - FORG), SeaSpine Holdings Corporation (Nasdaq - SPNE), LogicBio Therapeutics, Inc. (Nasdaq – LOGC),
From Brodsky & Smith LLC
Via GlobeNewswire
Myovant Sciences Announces Corporate Updates and Financial Results for Second Fiscal Quarter 2022
From Myovant Sciences, Inc.
Via GlobeNewswire
MYOVANT SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV
From Kahn Swick & Foti, LLC
Via Business Wire
Myovant Sciences Cancels Second Quarter Earnings Conference Call
From Myovant Sciences, Inc.
Via GlobeNewswire
MYOV STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Myovant Sciences Ltd. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement
From Myovant Sciences, Inc.
Via GlobeNewswire
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
From Myovant Sciences, Inc.
Via GlobeNewswire
CORRECTION -- Myovant Sciences, Inc.
From Myovant Sciences, Inc.
Via GlobeNewswire
Myovant Sciences to Host Second Fiscal Quarter 2022 Earnings Conference Call at 5:00 p.m.
From Myovant Sciences, Inc.
Via GlobeNewswire
Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to Acquire Remaining Shares
From Myovant Sciences, Inc.
Via GlobeNewswire
Myovant Sciences Announces Corporate Updates and Financial Results for First Fiscal Quarter 2022
From Myovant Sciences, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.